Recreating Human Skin In Vitro: Should the Microbiota Be Taken into Account?
Open accessAbstract
Skin plays crucial roles in the human body: besides protecting the organism from external threats, it acts as a thermal regulator, is responsible for the sense of touch, hosts microbial communities (the skin microbiota) involved in preventing the invasion of foreign pathogens, contains immunocompetent cells that maintain a healthy immunogenic/tolerogenic balance, and is a suitable route for drug administration. In the skin, four defense levels can be identified: besides the physical, chemical, and immune barriers that are inherent to the tissue, the skin microbiota (i.e., the numerous microorganisms living on the skin surface) provides an additional barrier. Studying the skin barrier function or the effects of drugs or cosmetic agents on human skin is a difficult task since snapshot evidence can only be obtained using bioptic samples where dynamic processes cannot properly be followed. To overcome these limitations, many different in vitro models of human skin have been developed that are characterized by diverse levels of complexity in terms of chemical, structural, and cellular composition. The aim of this review is to summarize and discuss the advantages and disadvantages of the different human skin models so far available and to underline how the insertion of a proper microbiota would positively impact an in vitro human skin model in an attempt to better mimic conditions in vivo.
AI snapshot
Written from the paper’s full text.
TL;DR
This review surveys in vitro human skin models from artificial membranes to organoids, organ-on-a-chip, 3D bioprinting, and ex vivo explants, comparing their complexity and limitations. It argues that incorporating the complete skin microbiota would improve fidelity to native skin, though most current models lack appendages and suitable conditions for full microbiota.
Key findings
- The review describes four skin barriers—physical, chemical, immune, and microbiota—and states that the microbiota contributes to colonization resistance, antimicrobial peptide induction, tight-junction protein expression, lipid/pH maintenance, and immune modulation.
- Increasing model complexity improves physiological relevance, but none fully reproduces native skin: artificial membranes lack cells; 2D models lack stratum corneum and 3D organization; HSEs lack all original cell populations, appendages, and vessels; spheroids/organoids lack an air-liquid interface, vascularization, and immune cells; organ-on-chip and bioprinting face vascularization and appendage limits; ex vivo explants preserve structure but have ethical, variability, and preservation constraints.
- Evidence for microbiota integration includes Loomis et al., who found community effects on epidermal thickness, epidermal cell proliferation, and filaggrin production that were not entirely driven by any single microorganism, and Landemaine et al., who reported that full skin microbiota on a 3D model remained stable up to 7 days and produced a more proliferative epidermis with higher desmosome and tight-junction protein expression than S. epidermidis alone.
- Quantitative examples include retinol permeation nearly 40-fold greater with jojoba oil in a skin PAMPA; spheroids usually between 65 and 300 µm when produced using spinner flasks; and Vahav et al. culturing an air-exposed epidermis with neopapillae spheroids under dynamic flow for 10 days, finding dose-dependent cinnamaldehyde cytotoxicity and cytokine release.
Methods
- Narrative review; literature survey through PubMed and Scopus using “skin models”, “in vitro human skin”, and “microbiota” as search terms, considering papers published over the last ten years, with the most relevant skin-model papers since 2018.
- No primary experimental data, sample, or statistical analysis are reported; the paper synthesizes and discusses advantages and disadvantages of different human skin models and the potential addition of microbiota.
Limitations
- The paper states limitations of the reviewed models: artificial membranes lack cells; 2D models lack 3D organization and stratum corneum and cannot be maintained with bacteria for more than 24 h; HSEs lack original cell populations, appendages, and vessels and may have altered barrier formation; spheroids lack an air-liquid interface and vascularization and have difficult-to-control geometry/size; organoids lack immune cells and vascularization and have limited lifespan; organ-on-chip models face flow-stability and tubing issues; ex vivo explants require ethical permission, show inter- and intra-sample variability, and have limited structural/functional preservation.
- The paper states that most current skin models lack appendages such as sebaceous glands and hair follicles, limiting co-culture of anaerobic bacteria like Cutibacterium and thus a complete human skin microbiota; pre-surgical prophylaxis may also alter the native microbiome in explants.
- Text makes evident: as a narrative review, it does not report a systematic search strategy, inclusion/exclusion criteria, risk-of-bias assessment, or quantitative synthesis, and it presents no own experimental validation.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
32 of 55 cited sources checked · 14 supported · 1 flagged · accuracy not yet measured
- Premisecitation
In the skin, four defense levels can be identified: physical, chemical, and immune barriers inherent to the tissue, plus the skin microbiota, which provides an additional barrier.
“In the skin, four defense levels can be identified: besides the physical, chemical, and immune barriers that are inherent to the tissue, the skin microbiota (i.e., the numerous microorganisms living on the skin surface) provides an additional barrier.”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [4] Fournière, M., Latire, T., Souak, D., Feuilloley, M.G., and Bedoux, G. (2020). Staphylococcus epidermidis and Cutibacterium acnes: Two major sentinels of skin microbiota and the influence of cosmetics. Microorganisms, 8. source
The Introduction describes the stratum corneum as a physical barrier and says skin microorganisms help maintain the skin barrier and immune system while limiting pathogen growth. Section 2.1 also describes antimicrobial substances produced by commensal bacteria. The paper does not identify four distinct defense levels or describe a separate chemical barrier inherent to the tissue; page numbers are unavailable in our copy. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [5] Byrd, 2018, The human skin microbiome, Nat. Rev. Microbiol. source
- Premisecitation
A positive correlation was observed for total permeated phenoxyethanol between skin PAMPA and porcine or human skin in a Franz diffusion cell.
“notably, the authors observed a positive correlation for the total amount of permeated phenoxyethanol between this artificial membrane and porcine or human skin placed in a Franz diffusion cell, a widely used system to test drug permeation in vitro [16,17,18].”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [16] Rahma, 2023, A comparative study of the in vitro permeation of 2-phenoxyethanol in the skin PAMPA model and mammalian skin, Int. J. Pharm. source
- cites [17] Kumar, M., Sharma, A., Mahmood, S., Thakur, A., Mirza, M.A., and Bhatia, A. (2023). Franz diffusion cell and its implication in skin permeation studies. J. Dispers. Sci. Technol., 1–14. source
- cites [18] Salamanca, 2018, Franz diffusion cell approach for pre-formulation characterisation of ketoprofen semi-solid dosage forms, Pharmaceutics source
- Premisecitation
Ibuprofen was more permeable through skin PAMPA and silicone membrane than through human and porcine tissue.
“Luo et al. [20] performed a comparative study of ibuprofen permeation using human and porcine tissue, a skin PAMPA model, and a silicone membrane and found that the drug was more permeable through the PAMPA and the silicone membrane than through the animal tissues.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [20] Luo, 2016, A comparative study of the in vitro permeation of ibuprofen in mammalian skin, the PAMPA model and silicone membrane, Int. J. Pharm. source
- Premisecitation
Alteration of the microbial communities, due to environmental, genetic, lifestyle-associated, hygienic, and immune system-related factors, can lead to a pathological skin condition by making ordinarily beneficial bacteria disease-causing under certain conditions.
“Indeed, as a result of environmental, genetic, lifestyle-associated, hygienic, and immune system-related factors, the alteration of the microbial communities can lead to a pathological skin condition; it means that these factors can have an impact on ordinarily beneficial bacteria, making them disease-causing under certain conditions [5,128].”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [5] Byrd, 2018, The human skin microbiome, Nat. Rev. Microbiol. source
- cites [128] Findley, K., and Grice, E.A. (2014). The skin microbiome: A focus on pathogens and their association with skin disease. PLoS Pathog., 10. source
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
- Premisecitation
Loomis et al. found a community effect in microbiome-host signaling: effects of the microbial community on epidermal thickness, epidermal cell proliferation, and filaggrin production were not entirely driven by any single microorganism.
“From the obtained results, the authors suggested a community effect in microbiome-host signaling since the effects obtained by the presence of the microbial community (i.e., changes in epidermal thickness, epidermal cell proliferation, and filaggrin production) were not entirely driven by any single microorganism.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [136] Loomis, K.H., Wu, S.K., Ernlund, A., Zudock, K., Reno, A., Blount, K., and Karig, D.K. (2021). A mixed community of skin microbiome representatives influences cutaneous processes more than individual members. Microbiome, 9. source
- Premisecitation
The microporous cellulose acetate membrane is useful for studying topical diffusion and release of chemical agents.
“In the first group, we find the microporous cellulose acetate (CA) membrane that is useful for studying the topical diffusion and release of chemical agents [12].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [12] Haq, 2018, Membrane properties for permeability testing: Skin versus synthetic membranes, Int. J. Pharm. source
- Premisecitation
Skin PAMPAs contain free fatty acid, cholesterol, and synthetic ceramide analogs mimicking the stratum corneum.
“In order to overcome this limitation, lipid-based skin models have been developed, such as the skin PAMPAs (Parallel Artificial Membrane Permeability Assays), which contain free fatty acid, cholesterol, and synthetic ceramide analogs mimicking the stratum corneum [12,14]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [12] Haq, 2018, Membrane properties for permeability testing: Skin versus synthetic membranes, Int. J. Pharm. source
- cites [14] Mossahebi, 2019, Investigation of the compatibility of the skin PAMPA model with topical formulation and acceptor media additives using different assay setups, AAPS PharmSciTech source
- Premisecitation
Among the protective and homeostatic functions of the skin microbiota, a key role is played by colonization resistance, which protects against pathogenic bacteria through competitive growth and production of antimicrobial peptides (AMPs).
“Among the protective and homeostatic functions of the skin microbiota, a key role is played by the “colonization resistance”, indicating the protection against pathogenic bacteria due to competitive growth but also to the production of antimicrobial peptides (AMPs) [5].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [5] Byrd, 2018, The human skin microbiome, Nat. Rev. Microbiol. source
- Interpretationreasoning
The development of a human skin model with complete microbiota is justified by the inadequacy of in vivo animal models for this purpose.
“The development of such a model is justified also by the inadequacy of the in vivo animal models in this sense.”
Quote in the paperSubstantial claim - Interpretationreasoning
Not all in vitro human skin models previously presented are suitable to host the human skin microbiota.
“However, not even all the in vitro human skin models previously presented are suitable to host the human skin microbiota.”
Quote in the paperSubstantial claim- Rests on an assumption: Synthetic membranes lack cells, so microorganisms cannot establish symbiotic relationships.
- Interpretationcitation
The addition of full skin microbiota to a 3D skin model has a positive impact, promoting keratinocyte proliferation and cohesion.
“these results suggest the positive impact of the microbiota over the 3D skin model, promoting keratinocytes proliferation and cohesion.”
Quote in the paperSubstantial claim - Interpretationreasoning
The simplified stratum corneum model is limited for studying skin permeation or recreating full tissue complexity because it only recreates the outermost skin layer, excluding all other components of the multilayered tissue.
“This model is clearly interesting due to its simplicity, but its intrinsic limitation as a model to study skin permeation or in recreating the full tissue complexity is obvious since only the outermost skin layer is recreated, thus excluding all the other components of the multilayered tissue.”
Quote in the paperSubstantial claim - Interpretationcitation
The integration of the full skin microbiota is crucial in the human skin in vitro model.
“These results point out once again that the integration of the full skin microbiota is crucial in the human skin in vitro model.”
Quote in the paperSubstantial claim - Interpretationreasoning
The interaction between keratinocytes and microbiota is essential for the proper barrier function of the skin.
“The interaction between keratinocytes and microbiota is thus essential for the proper barrier function of the skin.”
Quote in the paperSubstantial claim - Interpretationreasoning
The passage to 3D or ex vivo-based models is compulsory for studying skin-microbiota relationships.
“Thus, the passage to 3D or ex vivo-based models is compulsory.”
Quote in the paperSubstantial claim- Rests on an assumption: Synthetic membranes lack cells, so microorganisms cannot establish symbiotic relationships.
- Interpretationreasoning
In an in vitro skin model, the presence of the diversified cellular populations normally present in skin tissue is essential to ensure a more in vivo-like situation.
“the presence of the diversified cellular populations and neurovascular and stromal organization normally present in the tissue are essential to ensure a more in vivo-like situation.”
Quote in the paperSubstantial claim - Interpretationreasoning
In an in vitro skin model, the presence of neurovascular and stromal organization normally present in skin tissue is essential to ensure a more in vivo-like situation.
“the presence of the diversified cellular populations and neurovascular and stromal organization normally present in the tissue are essential to ensure a more in vivo-like situation.”
Quote in the paperSubstantial claim
- May combine two claims. 27
- Classified as probably not a substantial claim. 5
May combine two claims.
PremisecitationAD is associated with increased abundance of S. aureus in lesions, which interferes with host immunity and damages the skin barrier; psoriasis is associated with abnormal colonization of S. aureus and decreased S. epidermidis abundance in psoriatic lesions; seborrheic dermatitis involves Malassezia in its pathogenesis.
“Further examples of disease-microbiota association in human skin are AD (where the increased abundance of S. aureus in the lesions interferes with the host immunity, directly damaging the skin barrier), psoriasis (with abnormal colonization of S. aureus and decrease of S. epidermidis abundance in psoriatic lesions), and seborrheic dermatitis (where the most abundant fungal skin commensal, Malassez”
Quote in the paperSubstantial claim4 of 4 sources checked- cites [122] Grice, 2011, The skin microbiome, Nat. Rev. Microbiol. source
Split into 3 atoms — 0 confirmed, 2 partially supported, 1 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured - cites [126] Lee, H.J., and Kim, M. (2022). Skin barrier function and the microbiome. Int. J. Mol. Sci., 23. source
Split into 2 atoms — 1 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 1 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured - cites [128] Findley, K., and Grice, E.A. (2014). The skin microbiome: A focus on pathogens and their association with skin disease. PLoS Pathog., 10. source
Split into 3 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 1 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured - cites [129] Carmona-Cruz, S., Orozco-Covarrubias, L., and Sáez-de-Ocariz, M. (2022). The human skin microbiome in selected cutaneous diseases. Front. Cell Infect. Microbiol., 12. source
May combine two claims.
InterpretationcitationArtificial membranes are distant from the in vivo condition because they lack cells and intercellular matrix, but they are useful for screening chemical-physical characteristics of compounds.
“The first cited models consist of artificially generated membranes: they are quite distant from the in vivo condition due to the lack of cells and intercellular matrix, but they can be useful for screening with respect to the chemical-physical characteristics of the compounds to be tested.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [11] Moniz, 2020, Human skin models: From healthy to disease-mimetic systems; characteristics and applications, Br. J. Pharamcol. source
Section 4.2 describes artificial membranes as distinct from cell cultures and says simple membrane models lack similarity with human skin but are useful for testing diffusion and drug permeation. It also describes a lipid-based membrane model that can screen drug candidates. The section does not specifically say that these membranes screen compounds’ physicochemical characteristics or identify the absence of intercellular matrix as the reason they differ from living skin. (LLM, conf=0.82)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationDuring organism growth, bacterial populations gradually adapt to the skin environment, and microbiota colonization continues until equilibrium is reached in adulthood.
“During the organism’s growth, the bacterial populations gradually adapt to the skin environment, and the microbiota colonization continues until equilibrium is reached in adulthood [8,9,10].”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [8] Somerville, 1969, The normal flora of the skin in different age groups, Br. J. Dermatol. source
- cites [9] Leyden, 1975, Age-related changes in the resident bacterial flora of the human face, J. Investig. Dermatol. source
- cites [10] Hu, 2023, Changes in the skin microbiome during male maturation from 0 to 25 years of age, Skin Res. Technol. source
May combine two claims.
PremisecitationIn humans, skin microbiota is acquired at birth because the skin is sterile in utero; colonization occurs minutes after birth by the mother's commensal microorganisms, and this neonatal process is crucial to establish immune tolerance towards them.
“In humans, skin microbiota is acquired at birth since, in utero, the skin is sterile; skin colonization occurs a few minutes after birth by the mother’s commensal microorganisms, and this process in the neonatal stage is crucial to establish immune tolerance towards them [6,7].”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [6] Mueller, 2015, The infant microbiome development: Mom matters, Trends Mol. Med. source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured - cites [7] Capone, 2011, Diversity of the human skin microbiome early in life, J. Investig. Dermatol. source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationThe skin microbiota, or dermobiota, comprises bacteria, fungi, viruses, archaea, and mites on the skin surface and forms a complex ecosystem that keeps pathogenic bacteria under control and releases activating/modulating substances for epidermal and immune cells, favoring maintenance of whole barrier functions.
“the skin microbiota, or dermobiota (i.e., the bacteria, fungi, viruses, archaea, and mites present on the skin surface) forms a complex ecosystem that keeps pathogenic bacteria under control and releases activating/modulating substances for the epidermal and immune cells, thus favoring the maintenance of the whole barrier functions [4,5].”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [4] Fournière, M., Latire, T., Souak, D., Feuilloley, M.G., and Bedoux, G. (2020). Staphylococcus epidermidis and Cutibacterium acnes: Two major sentinels of skin microbiota and the influence of cosmetics. Microorganisms, 8. source
- cites [5] Byrd, 2018, The human skin microbiome, Nat. Rev. Microbiol. source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationSkin PAMPAs are 96-well plate-based systems with an artificial membrane between donor and acceptor compartments, used as high-throughput assays for preliminary screening and permeation- and stability-related insights into topical and transdermal formulations.
“the skin PAMPAs are 96-well plate-based systems where an artificial membrane is interposed between a donor and an acceptor compartment, in a sandwich-like structure. These systems attracted the attention of researchers as high-throughput assays for the preliminary screening and for obtaining permeation- and stability-related insights into topical and transdermal formulations [14,15].”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [14] Mossahebi, 2019, Investigation of the compatibility of the skin PAMPA model with topical formulation and acceptor media additives using different assay setups, AAPS PharmSciTech source
- cites [15] Neupane, R., Boddu, S.H., Renukuntla, J., Babu, R.J., and Tiwari, A.K. (2020). Alternatives to biological skin in permeation studies: Current trends and possibilities. Pharmaceutics, 12. source
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationSkin PAMPAs lack stratified epidermal tissue, skin macromolecules, cell populations, and appendages, and their stratum corneum-mimicking lipid mixture does not contain all lipid subclasses normally present in human skin.
“In particular, they lack the stratified epidermal tissue and all the wide set of skin macromolecules, cell populations, and appendages, while the lipid mixture mimicking the stratum corneum does not contain all the lipid subclasses normally present in the human skin [9,10].”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [9] Leyden, 1975, Age-related changes in the resident bacterial flora of the human face, J. Investig. Dermatol. source
- cites [10] Hu, 2023, Changes in the skin microbiome during male maturation from 0 to 25 years of age, Skin Res. Technol. source
The Discussion describes changes in the facial skin microbiome during male maturation, not the composition or limitations of skin PAMPAs. Searches for stratified epidermal tissue and for missing stratum corneum lipid subclasses found no passage addressing the claim. Page numbers were not available in our copy. (LLM, conf=0.77)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationThe array of microorganisms colonizing the epidermal surface is fairly stable and depends on the skin site (biogeography), with changes in the relative abundance of bacterial taxa associated with moist-, dry-, and sebum-rich microenvironments.
“The array of microorganisms colonizing the epidermal surface is fairly stable and depends on the skin site (the so-called “biogeography” factor), with changes in the relative abundance of the bacterial taxa associated with moist-, dry- and sebum-rich microenvironments.”
Quote in the paperNot a substantial claim1 of 2 sources checkedMay combine two claims.
PremisecitationThe skin consists of four morphologically and functionally related barriers-physical, chemical, immune, and microbiotic-that form an interactive network whose disruption may lead to infection, inflammation, allergy, or cancer.
“As already recalled, the skin has been described as consisting of four morphologically and functionally related barriers: the physical, chemical, immune, and microbiotic barriers that form an interactive network whose disruption may lead to infection, inflammation, allergy, or even cancer [4,5].”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [4] Fournière, M., Latire, T., Souak, D., Feuilloley, M.G., and Bedoux, G. (2020). Staphylococcus epidermidis and Cutibacterium acnes: Two major sentinels of skin microbiota and the influence of cosmetics. Microorganisms, 8. source
The Introduction describes a physical barrier and says skin microorganisms help maintain the skin barrier and immune system. Section 2.2 links barrier disturbance and microbiota imbalance with inflammatory skin disease, but says the causal relationship remains unclear. The paper does not describe the claimed four-barrier framework or link its disruption to allergy or cancer; page numbers are not available in our copy. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [5] Byrd, 2018, The human skin microbiome, Nat. Rev. Microbiol. source
May combine two claims.
PremisecitationThe human skin microbiota contains a variety of bacterial species and, unlike the gut microbiota, is mostly made of Gram-positive Actinobacteria (e.g., Cutibacterium spp. and Corynebacterium spp.), including Gram-positive Staphylococcus.
“Genomics-based investigation showed that a variety of different bacterial species coexist in the human skin microbiota, which, in contrast to the gut microbiota, is mostly made of Gram-positive Actinobacteria (e.g., Cutibacterium spp. and Corynebacterium spp.), including the Gram-positive Staphylococcus [122].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [122] Grice, 2011, The skin microbiome, Nat. Rev. Microbiol. source
The Molecular analysis of skin microbiota section reports diverse skin bacteria and says Actinobacteria are more abundant on skin than in the gut. The Variation by skin site subsection identifies Corynebacterium and Staphylococcus on skin, but the paper places Actinobacteria and Firmicutes in separate phyla; it does not support describing Staphylococcus as included among Actinobacteria. Our copy uses Propionibacterium rather than Cutibacterium. (LLM, conf=0.88)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationStaphylococcus epidermidis inhibits colonization by pathogenic S. aureus and induces AMP expression, resulting in innate immune alertness; it may also enhance epidermal barrier function by increasing expression of tight-junction proteins occludin and ZO-1.
“For example, the natural cutaneous commensal, Staphylococcus epidermidis inhibits the colonization by the pathogenic S. aureus and induces the expression of AMPs, resulting in S. epidermidis-orchestrated innate immune alertness; additionally, it may enhance the epidermal barrier function stimulating the increased expression of the tight-junction proteins, occludin and ZO-1 [124,125].”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [124] Brandwein, 2017, Endogenous antimicrobial peptide expression in response to bacterial epidermal colonization, Front. Immunol. source
Split into 2 atoms — 0 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 1 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured - cites [125] Ohnemus, 2008, Regulation of epidermal tight-junctions (TJ) during infection with exfoliative toxin-negative Staphylococcus strains, J. Investig. Dermatol. source
May combine two claims.
PremisecitationThe efficacy of the epidermal barrier is the outcome of crosstalk between the different skin barrier levels, with the microbiota contributing physically, chemically, microbially, and immunologically; these functions are guaranteed by a strictly-regulated and finely balanced microbiota.
“Thus, the efficacy of the epidermal barrier is the outcome of the crosstalk between the different skin barrier levels, with the microbiota contributing to the skin barrier from a physical, chemical, microbial, and innate/adaptive immunological point of view; these functions are guaranteed by a strictly-regulated and finely balanced microbiota [126].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [126] Lee, H.J., and Kim, M. (2022). Skin barrier function and the microbiome. Int. J. Mol. Sci., 23. source
May combine two claims.
PremisecitationSome components of the skin microbiota secrete lipase enzymes that hydrolyze free fatty acids from sebum triglycerides, maintaining low skin pH, preserving the acid mantle, and stimulating production of β-defensin 2.
“From the chemical barrier point of view, some components of the skin microbiota have an important role in secreting lipase enzymes that hydrolyze free fatty acids from the triglycerides present in sebum, maintaining in this way a low skin pH, preserving the acid mantle, but also stimulating the skin immunity in producing β-defensin 2 [123,126].”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [123] Boxberger, M., Cenizo, V., Cassir, N., and La Scola, B. (2021). Challenges in exploring and manipulating the human skin microbiome. Microbiome, 9. source
The ‘maintenance of skin homeostasis’ section says microbial lipases help break down the skin’s surface lipid film and that sebum and free fatty acids help regulate skin pH. The Introduction also links fatty acids to skin acidification. Neither passage specifies hydrolysis of sebum triglycerides, preservation of the acid mantle, or stimulation of β-defensin 2 production; the immune-system section discusses antimicrobial peptides only generally. Page numbers are unavailable in our copy. (LLM, conf=0.87)
Experimental — accuracy not yet measured - cites [126] Lee, H.J., and Kim, M. (2022). Skin barrier function and the microbiome. Int. J. Mol. Sci., 23. source
Classified as probably not a substantial claim.
InterpretationreasoningAdding the complete microbiota to colonize the apical side of human skin models would make them closer to the in vivo condition.
“For this reason, it is to be foreseen to improve human skin models by adding the complete microbiota to colonize the apical side of the model in order to get closer and closer to the in vivo condition [130,131,132].”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [130] Niehues, 2018, 3D skin models for 3R research: The potential of 3D reconstructed skin models to study skin barrier function, Exp. Dermatol. source
- cites [131] Rademacher, 2018, Skin microbiota and human 3D skin models, Exp. Dermatol. source
- cites [132] Bojar, 2015, Studying the human skin microbiome using 3D in vitro skin models, Appl. Vitr. Toxicol. source
May combine two claims.
Premisecitation2D models are not suitable for emulating the relationship between skin and microbiota because they lack the stratum corneum, causing microorganisms to contact proliferating keratinocytes and fibroblasts (which does not happen in vivo), and because bacteria grow faster than human cells, preventing maintenance for more than 24 h.
“Even the 2D models are not suitable for the development of systems capable of emulating the relationship between skin and microbiota. In fact, they lack the stratum corneum, and so the microorganisms would come in direct contact with proliferating keratinocytes and fibroblasts, which does not happen in vivo; moreover, these systems are disadvantaged by the faster growth rate of bacteria compared”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [28] Pérez-Salas, J.L., Moreno-Jiménez, M.R., Rocha-Guzmán, N.E., González-Laredo, R.F., Medina-Torres, L., and Gallegos-Infante, J.A. (2023). In Vitro and Ex Vivo Models for Screening Topical Anti-Inflammatory Drugs. Sci. Pharm., 91. source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured - cites [123] Boxberger, M., Cenizo, V., Cassir, N., and La Scola, B. (2021). Challenges in exploring and manipulating the human skin microbiome. Microbiome, 9. source
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
May combine two claims.
Premisecitationvan Der Krieken et al. developed a simplified human skin model consisting of the stratum corneum only (human callus on top of agar in phosphate-buffered saline) and planted the complete microbiota from the back of healthy volunteers onto it; the model supported growth of the most relevant strains and the complete set of skin microbes normally found in vivo, which remained relatively stable for 7天.
“An interesting study was performed by van Der Krieken et al. [140], who planted the complete microbiota taken from the back of healthy volunteers onto an originally developed simplified human skin model, which consisted in the reproduction of the stratum corneum only by using human callus on top of agar in phosphate-buffered saline. Since in vivo skin bacteria live attached to the dead corneocytes”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [140] Ederveen, 2016, An in vitro model for bacterial growth on human stratum corneum, Acta Derm. Venereol. source
May combine two claims.
InterpretationcitationThe use of human skin explants is more suitable for hosting the complete microbiota, but systemic pre-surgical prophylaxis may affect the integrity of the native microbiome, a problem that can only be overcome by using skin explants from non-prophylaxed donors.
“Therefore, the use of human skin explants is certainly more suitable, but the systemic pre-surgical prophylaxis normally performed before surgical operations may affect the integrity of the native microbiome, a problem that can only be overcome by using skin explants deriving from non-prophylaxed donors [133].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [133] Larson, 2021, Challenges in developing a human model system for skin microbiome research, J. Investig. Dermatol. source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationRodent skin has its own microbiota that differs from human skin microbial communities, and attempts to model human microbiota on animal skin are prevented by competition from the native flora, in addition to intrinsic morphological differences with human skin.
“Indeed, besides having intrinsic morphological differences with human skin, disadvantaging germ-free animal models, rodent skin is characterized by its own microbiota, which obviously differs from the microbial communities of human skin; thus, the attempts to model human microbiota on animal skin are prevented due to the competition exerted by the native flora [133,134].”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [133] Larson, 2021, Challenges in developing a human model system for skin microbiome research, J. Investig. Dermatol. source
- cites [134] Emmert, 2020, Skin microbiota analysis in human 3D skin models—“Free your mice”, Exp. Dermatol. source
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationMost skin models used nowadays for the study of barrier functions lack skin appendages such as sebaceous glands and hair follicles; as a consequence, it is difficult or even impossible to co-culture bacteria strains that grow within anaerobic environments like Cutibacterium, limiting the culturing of a complete human skin microbiota.
“However, most of the skin models used nowadays for the study of barrier functions lack skin appendages such as sebaceous glands and hair follicles; as a consequence, it is difficult or even impossible to co-culture bacteria strains that grow within anaerobic environments like Cutibacterium, limiting in this way the culturing of a complete human skin microbiota [136].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [136] Loomis, K.H., Wu, S.K., Ernlund, A., Zudock, K., Reno, A., Blount, K., and Karig, D.K. (2021). A mixed community of skin microbiome representatives influences cutaneous processes more than individual members. Microbiome, 9. source
Classified as probably not a substantial claim. May combine two claims.
Premisenone givenIn vitro skin models have been designed to obtain reliable data on biocompatibility, penetrability, safety, and efficacy of tested compounds, and their complexity has progressively improved to approach native skin.
“The skin models in vitro have been designed to obtain reliable data on the biocompatibility, penetrability, safety, and efficacy of tested compounds, and their complexity has progressively improved to approach a reliable similarity to the native skin.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThe skin microbiota prevents pathogen invasion, but when the balance between commensals and pathogens is altered, the barrier may break and skin diseases or systemic disorders can occur.
“Serving as a physical barrier, the skin microbiota prevents the invasion of pathogens, but when the balance between commensals and pathogens is altered, the barrier may be broken, and skin diseases (and sometimes even systemic disorders) can occur [5].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [5] Byrd, 2018, The human skin microbiome, Nat. Rev. Microbiol. source
May combine two claims.
PremisecitationCellulose acetate membranes lack the fluid lipid component normally present in the stratum corneum of in vivo skin, which is one of the main barriers to drug penetration.
“In addition, CA membranes also lack the fluid lipid component, which is normally present in the stratum corneum of the in vivo skin and is one of the main barriers to drug penetration [12,13].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [12] Haq, 2018, Membrane properties for permeability testing: Skin versus synthetic membranes, Int. J. Pharm. source
- cites [13] Simon, 2013, Nanoemulsion containing dapsone for topical administration: A study of in vitro release and epidermal permeation, Int. J. Nanomed.
Not checked in the free run.
May combine two claims.
PremisecitationCellulose acetate membranes have a pore size larger than human skin, causing a higher permeation rate than the native biological barrier; dapsone permeated more through CA membranes than through pig ear epidermis.
“However, these systems have several disadvantages, e.g., the pore size of CA is larger than in human skin, thus causing a higher permeation rate than that found in the native biological barrier (in fact, de Almedida Borges and colleagues [13] observed a higher permeation of dapsone through CA membranes compared to the permeation observed in pig ear epidermis).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [13] Simon, 2013, Nanoemulsion containing dapsone for topical administration: A study of in vitro release and epidermal permeation, Int. J. Nanomed.
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningThe development of skin appendages-containing human skin models would be important.
“Thus, the development of skin appendages-containing human skin models would be important.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationLandemaine et al. showed that adding a full skin microbiota collected from the inner forearm of a volunteer to a 3D skin model results in a stable number of bacteria up to 7 days, with a more proliferative epidermis showing higher expression of desmosome and tight junction proteins compared to the same model with only S. epidermidis added.
“This aspect was also underlined by Landemaine et al. [137], who showed that the addition of a full skin microbiota collected from the inner forearm of a volunteer to a 3D skin model results in a stable number of bacteria up to 7 days, with a more proliferative epidermis showing a higher expression of proteins of desmosomes and tight junctions when compared to the same model but with the addition”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [137] Landemaine, 2018, 961 Colonization of a 3D skin model with a complete microbiota is more beneficial to the skin barrier than with Staphylococcus epidermidis alone, J. Investig. Dermatol. source
May combine two claims.
PremisecitationBoth a transepidermal and a transappendageal pathway exist in skin for formulation permeation.
“since both a transepidermal and a transappendageal pathway exist [142]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [142] Vitorino, 2015, Overcoming the skin permeation barrier: Challenges and opportunities, Curr. Pharm. Des. source
May combine two claims.
InterpretationcitationThe symbiotic relationship between the tissue and the microorganisms living on its surface underlines the importance of integrating them in in vitro systems, obtaining positive effects on the growth and cohesion of skin cells, which are reflected on an improved barrier function.
“The symbiotic relationship existing between the tissue and the microorganisms living on its surface underlines the importance of integrating them in these in vitro systems, obtaining in this way positive effects on the growth and cohesion of skin cells, which are then reflected on an improved barrier function.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningFor a correct evaluation of formulation permeability, the chosen in vitro model should have the same complexity as the skin organ.
“It is easy to understand that the same complexity found in this organ should be present in the chosen model for a correct evaluation of the formulation permeability”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningTo better mimic human skin, in vitro models should be able to host complete microbiota communities; to do so, the presence of skin appendages like sebaceous glands is important for skin-related microbes living in anaerobic environments.
“Thus, to better mimic the human skin, these models should also be able to host the complete microbiota communities: to do so, the presence of skin appendages like sebaceous glands is important for all those skin-related microbes living in these anaerobic environments.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningThe use of human skin explants could solve the issues of hosting complete microbiota, but preservation after explant, difficulty in finding them, inter-subject variability, and possible alteration of microbiota due to pre-surgical prophylaxis could limit their use.
“The use of human skin explants could solve all these issues, but the preservation after the explant, the difficulty in finding them, the inter-subject variability, and the possible alteration of the microbiota due to pre-surgical prophylaxis could limit their use.”
Quote in the paperSubstantial claim
The paper relies on this without support.
Synthetic membranes lack cells, so microorganisms cannot establish symbiotic relationships.
“Synthetic membranes have an intrinsic limitation: the cells are not present in these models, and the different microorganisms could not establish any symbiotic relationship.”
The paper relies on this without support.
In the literature, very few human skin models have used the complete skin microbiota.
“In the literature, it is possible to find human skin models where single commensal species were added, but very few used the complete skin microbiota.”
The paper relies on this without support.
Skin microbiota is a constituent normally found in vivo.
“including the skin microbiota”
Cites
Biomaterials & scaffolds for tissue engineering
O'Brien, F. J. (2011) · Materials Today · doi:10.1016/s1369-7021(11)70058-x · Cited by 3,437 · see citing works
Grice, E. A., & Segre, J. A. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2537 · Cited by 3,143 · see citing works
Byrd, A. L., Belkaid, Y., & Segre, J. A. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.157 · Cited by 2,806 · see citing works
Capturing complex 3D tissue physiology in vitro
Griffith, L. G., & Swartz, M. A. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1858 · Cited by 2,274 · see citing works
Human organoids: model systems for human biology and medicine
Kim, J., Koo, B.-K., & Knoblich, J. A. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0259-3 · Cited by 2,187 · see citing works
Scaffolding in tissue engineering: general approaches and tissue-specific considerations
Chan, B. P., & Leong, K. W. (2008) · European Spine Journal · doi:10.1007/s00586-008-0745-3 · Cited by 1,708 · see citing works
Is it time to start transitioning from 2D to 3D cell culture?
Jensen, C., & Teng, Y. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00033 · Cited by 1,640 · see citing works
Three-dimensional in vitro cell culture models in drug discovery and drug repositioning
Langhans, S. A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00006 · Cited by 1,522 · see citing works
Organoids as an in vitro model of human development and disease
Fatehullah, A., Tan, S. H., & Barker, N. (2016) · Nature Cell Biology · doi:10.1038/ncb3312 · Cited by 1,508 · see citing works
Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes
Rheinwald, J. G., & Green, H. (1977) · Nature · doi:10.1038/265421a0 · Cited by 1,067 · see citing works
The infant microbiome development: Mom matters
Mueller, N. T., Bakacs, E., Combellick, J., Grigoryan, Z., & Dominguez-Bello, M. G. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.12.002 · Cited by 943 · see citing works
Dialogue between skin microbiota and immunity
Belkaid, Y., & Segre, J. A. (2014) · Science · doi:10.1126/science.1260144 · Cited by 749 · see citing works
Diversity of the human skin microbiome early in life
Capone, K. A., Dowd, S. E., Stamatas, G. N., & Nikolovski, J. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.168 · Cited by 532 · see citing works
Organoid and Spheroid Tumor Models: Techniques and Applications
Gunti, S., Hoke, A. T. K., Vu, K., & London, N. R. (2021) · Cancers · doi:10.3390/cancers13040874 · Cited by 492 · see citing works
Methods for cultivation of keratinocytes with an air-liquid interface
Pruniéras, M., Régnier, M., & Woodley, D. (1983) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12540324 · Cited by 484 · see citing works
A Review of Three-Dimensional In Vitro Tissue Models for Drug Discovery and Transport Studies
Elliott, N. T., & Yuan, F. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22257 · Cited by 449 · see citing works
Scaffolds for Tissue Engineering and 3D Cell Culture
Carletti, E., Motta, A., & Migliaresi, C. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-984-0_2 · Cited by 388 · see citing works
van Smeden, J., & Bouwstra, J. A. (2016) · Current Problems in Dermatology · doi:10.1159/000441540 · Cited by 366 · see citing works
Alternatives to Biological Skin in Permeation Studies: Current Trends and Possibilities
Neupane, R., Boddu, S. H. S., Renukuntla, J., Babu, R. J., & Tiwari, A. K. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020152 · Cited by 351 · see citing works
Białkowska, K., Komorowski, P., Bryszewska, M., & Miłowska, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176225 · Cited by 341 · see citing works
Skin Barrier Function and the Microbiome
Lee, H.-J., & Kim, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113071 · Cited by 317 · see citing works
Sun, T. L., Jackson, S. J., Haycock, J. W., & MacNeil, S. (2006) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2005.12.021 · Cited by 309 · see citing works
3D bioprinting for skin tissue engineering: Current status and perspectives
Weng, T., Zhang, W., Xia, Y., Wu, P., Yang, M., Jin, R., Xia, S., Wang, J., You, C., Han, C., et al. (2021) · Journal of Tissue Engineering · doi:10.1177/20417314211028574 · Cited by 308 · see citing works
Cutaneous Barriers and Skin Immunity: Differentiating A Connected Network
Eyerich, S., Eyerich, K., Traidl‐Hoffmann, C., & Biedermann, T. (2018) · Trends in Immunology · doi:10.1016/j.it.2018.02.004 · Cited by 306 · see citing works
Skin integrated with perfusable vascular channels on a chip
Mori, N., Morimoto, Y., & Takeuchi, S. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.11.031 · Cited by 299 · see citing works
Pumpless microfluidic platform for drug testing on human skin equivalents
Abaci, H. E., Gledhill, K., Guo, Z., Christiano, A. M., & Shuler, M. L. (2014) · Lab on a Chip · doi:10.1039/c4lc00999a · Cited by 267 · see citing works
Bioinks and bioprinting: A focused review
Mobaraki, M., Ghaffari, M. S., Yazdanpanah, A., Luo, Y., & Mills, D. K. (2020) · Bioprinting · doi:10.1016/j.bprint.2020.e00080 · Cited by 260 · see citing works
Full-thickness human skin-on-chip with enhanced epidermal morphogenesis and barrier function
Sriram, G., Alberti, M., Dancik, Y., Wu, B., Wu, R., Feng, Z., Ramasamy, S., Bigliardi, P. L., Bigliardi‐Qi, M., & Wang, Z. (2017) · Materials Today · doi:10.1016/j.mattod.2017.11.002 · Cited by 258 · see citing works
Microtechnology-based methods for organoid models
Velasco, V., Shariati, S. A., & Esfandyarpour, R. (2020) · Microsystems & Nanoengineering · doi:10.1038/s41378-020-00185-3 · Cited by 253 · see citing works
Challenges in exploring and manipulating the human skin microbiome
Boxberger, M., Cenizo, V., Cassir, N., & La Scola, B. (2021) · Microbiome · doi:10.1186/s40168-021-01062-5 · Cited by 247 · see citing works
Proof-of-concept: 3D bioprinting of pigmented human skin constructs
Ng, W. L., Qi, J. T. Z., Yeong, W. Y., & Naing, M. W. (2018) · Biofabrication · doi:10.1088/1758-5090/aa9e1e · Cited by 244 · see citing works
Schäfer‐Korting, M., Bock, U., Diembeck, W., Düsing, H., Gamer, A. O., Haltner‐Ukomadu, E., Hoffmann, C., Kaca, M., Kamp, H., Kersen, S., et al. (2008) · Alternatives to Laboratory Animals · doi:10.1177/026119290803600207 · Cited by 239 · see citing works
Strat-M® synthetic membrane: Permeability comparison to human cadaver skin
Haq, A., Goodyear, B., Ameen, D., Joshi, V., & Michniak-Kohn, B. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.06.012 · Cited by 231 · see citing works
Fournière, M., Latire, T., Souak, D., Feuilloley, M. G. J., & Bedoux, G. (2020) · Microorganisms · doi:10.3390/microorganisms8111752 · Cited by 227 · see citing works
Niehues, H., Bouwstra, J. A., El Ghalbzouri, A., Brandner, J. M., Zeeuwen, P. L. J. M., & van den Bogaard, E. H. (2018) · Experimental Dermatology · doi:10.1111/exd.13531 · Cited by 210 · see citing works
Skin tissue engineering using 3D bioprinting: An evolving research field
Tarassoli, S. P., Jessop, Z. M., Al‐Sabah, A., Gao, N., Whitaker, S., Doak, S. H., & Whitaker, I. S. (2017) · Journal of Plastic Reconstructive & Aesthetic Surgery · doi:10.1016/j.bjps.2017.12.006 · Cited by 203 · see citing works
Advances in the Biofabrication of 3D Skin in vitro: Healthy and Pathological Models
Randall, M. J., Jüngel, A., Rimann, M., & Wuertz‐Kozak, K. (2018) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2018.00154 · Cited by 193 · see citing works
Age-related changes in the resident bacterial flora of the human face
Leyden, J. J., McGiley, K. J., Mills, O. H., & Kligman, A. M. (1975) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12607630 · Cited by 188 · see citing works
Salamanca, C. H., Barrera-Ocampo, A., Lasso, J. C., Camacho, N., & Yarce, C. J. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10030148 · Cited by 188 · see citing works
The Skin Microbiome: A Focus on Pathogens and Their Association with Skin Disease
Findley, K., & Grice, E. A. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004436 · Cited by 185 · see citing works
Friends or Foes? Host defense (antimicrobial) peptides and proteins in human skin diseases
Niyonsaba, F., Kiatsurayanon, C., Chieosilapatham, P., & Ogawa, H. (2017) · Experimental Dermatology · doi:10.1111/exd.13314 · Cited by 174 · see citing works
Tissue Engineered Human Skin Equivalents
Zhang, Z., & Michniak‐Kohn, B. B. (2012) · Pharmaceutics · doi:10.3390/pharmaceutics4010026 · Cited by 171 · see citing works
The Human Skin Microbiome in Selected Cutaneous Diseases
Carmona-Cruz, S., Orozco-Covarrubias, L., & Sáez-de-Ocariz, M. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.834135 · Cited by 170 · see citing works
Chaudhuri, R. K., & Bojanowski, K. (2014) · International Journal of Cosmetic Science · doi:10.1111/ics.12117 · Cited by 169 · see citing works
Surface Lipids as Multifunctional Mediators of Skin Responses to Environmental Stimuli
De Luca, C., & Valacchi, G. (2010) · Mediators of Inflammation · doi:10.1155/2010/321494 · Cited by 169 · see citing works
Vörsmann, H., Groeber, F., Walles, H., Busch, S., Beissert, S., Walczak, H., & Kulms, D. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.249 · Cited by 168 · see citing works
The normal flora of the skin in different age groups
SOMERVILLE, D. A. (1969) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1969.tb13976.x · Cited by 148 · see citing works
Microfluidic Skin‐on‐a‐Chip Models: Toward Biomimetic Artificial Skin
Sutterby, E., Thurgood, P., Baratchi, S., Khoshmanesh, K., & Pirogova, E. (2020) · Small · doi:10.1002/smll.202002515 · Cited by 142 · see citing works
Construction of 3D multicellular microfluidic chip for an in vitro skin model
Lee, S., Jin, S., Kim, Y. K., Sung, G. Y., Chung, J. H., & Sung, J. H. (2017) · Biomedical Microdevices · doi:10.1007/s10544-017-0156-5 · Cited by 140 · see citing works
Skin-on-a-chip models: General overview and future perspectives
Risueño, I., Valencia, L., Jorcano, J. L., & Velasco, D. (2021) · APL Bioengineering · doi:10.1063/5.0046376 · Cited by 138 · see citing works
Faller, C., Bracher, M. G., Dami, N., & Roguet, R. (2002) · Toxicology in Vitro · doi:10.1016/s0887-2333(02)00053-x · Cited by 137 · see citing works
Generation and characterization of hair-bearing skin organoids from human pluripotent stem cells
Lee, J., van der Valk, W. H., Serdy, S. A., Deakin, C., Kim, J., Le, A. P., & Koehler, K. R. (2022) · Nature Protocols · doi:10.1038/s41596-022-00681-y · Cited by 132 · see citing works
Ohnemus, U., Kohrmeyer, K., Houdek, P., Rohde, H., Wladykowski, E., Vidal, S., Horstkotte, M. A., Aepfelbacher, M., Kirschner, N., Behne, M. J., et al. (2008) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701070 · Cited by 124 · see citing works
Bolla, P. K., Clark, B. A., Juluri, A., Cheruvu, H. S., & Renukuntla, J. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020151 · Cited by 122 · see citing works
3D Bioprinting in Skin Related Research: Recent Achievements and Application Perspectives
Olejnik, A., Semba, J. A., Kulpa, A. M., Dańczak‐Pazdrowska, A., Rybka, J. D., & Gornowicz‐Porowska, J. (2021) · ACS Synthetic Biology · doi:10.1021/acssynbio.1c00547 · Cited by 114 · see citing works
A biofabricated vascularized skin model of atopic dermatitis for preclinical studies
Liu, X., Michael, S., Bharti, K., Ferrer, M., & Song, M. J. (2020) · Biofabrication · doi:10.1088/1758-5090/ab76a1 · Cited by 112 · see citing works
Alépée, N., Tornier, C., Robert, C., Amsellem, C., Roux, M.-H., Doucet, O., Pachot, J., Méloni, M., & de Fraissinette, A. D. B. (2009) · Toxicology in Vitro · doi:10.1016/j.tiv.2009.08.024 · Cited by 111 · see citing works
Human Defensins and Cathelicidins in the Skin: Beyond Direct Antimicrobial Properties
Niyonsaba, F., Nagaoka, I., & Ogawa, H. (2006) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v26.i6.60 · Cited by 109 · see citing works
Membrane properties for permeability testing: Skin versus synthetic membranes
Haq, A., Dorrani, M., Goodyear, B., Joshi, V., & Michniak-Kohn, B. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.01.029 · Cited by 107 · see citing works
Franz diffusion cell and its implication in skin permeation studies
Kumar, M., Sharma, A., Mahmood, S., Thakur, A., Mirza, M. A., & Bhatia, A. (2024) · Journal of Dispersion Science and Technology · doi:10.1080/01932691.2023.2188923 · Cited by 99 · see citing works
Lewis, N. S., Lewis, E. E., Mullin, M., et al. (2017) · Journal of Tissue Engineering · doi:10.1177/2041731417704428 · Cited by 91 · see citing works
Shed Snake Skin and Hairless Mouse Skin as Model Membranes for Human Skin During Permeation Studies
Rigg, P. C., & Barry, B. W. (1990) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12874561 · Cited by 91 · see citing works
Human skin explant model for the investigation of topical therapeutics
Neil, J. E., Brown, M. B., & Williams, A. C. (2020) · Scientific Reports · doi:10.1038/s41598-020-78292-4 · Cited by 90 · see citing works
Itoh, T., Xia, J., Magavi, R., et al. (1990) · Pharmaceutical Research · doi:10.1023/a:1015943200982 · Cited by 90 · see citing works
Nanoemulsion-based dissolving microneedle arrays for enhanced intradermal and transdermal delivery
Nasiri, M. I., Vora, L. K., Ershaid, J. M. A., Peng, K., Tekko, I. A., & Donnelly, R. F. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-01107-0 · Cited by 89 · see citing works
Three-Dimensional Cell Cultures in Toxicology
Pampaloni, F., & Stelzer, E. H. K. (2009) · Biotechnology and Genetic Engineering Reviews · doi:10.5661/bger-26-117 · Cited by 88 · see citing works
Epidermal morphogenesis during progressive in vitro 3 D reconstruction at the air–liquid interface
Frankart, A., Malaisse, J., Vuyst, É. D., Minner, F., de Rouvroit, C. L., & Poumay, Y. (2012) · Experimental Dermatology · doi:10.1111/exd.12020 · Cited by 87 · see citing works
Chen, L., Wu, M., Jiang, S., Zhang, Y., Li, R., Lu, Y., Liu, L., Wu, G., Liu, Y., Xie, L., et al. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s225451 · Cited by 87 · see citing works
In vitro models for evaluating safety and efficacy of novel technologies for skin drug delivery
Planz, V., Lehr, C., & Windbergs, M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.09.002 · Cited by 86 · see citing works
Skin organoids: a new human model for developmental and translational research
Lee, J., & Koehler, K. R. (2021) · Experimental Dermatology · doi:10.1111/exd.14292 · Cited by 85 · see citing works
Human skin models: From healthy to disease-mimetic systems; characteristics and applications
Moniz, T., Costa Lima, S. A., & Reis, S. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15184 · Cited by 80 · see citing works
Overcoming the skin permeation barrier: Challenges and opportunities
Vitorino, C., Sousa, J., & Pais, A. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150428124053 · Cited by 78 · see citing works
Kim, K., Kim, H., & Sung, G. Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042116 · Cited by 77 · see citing works
de Sousa, V. P., Borges, Simon, 。., et al. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s39383 · Cited by 77 · see citing works
Bioengineered skin organoids: from development to applications
Hong, Z.-X., Zhu, S.-T., Li, H., Luo, J.-Z., Yang, Y., An, Y., Wang, X., & Wang, K. (2023) · Military Medical Research · doi:10.1186/s40779-023-00475-7 · Cited by 77 · see citing works
Loomis, K. H., Wu, S. K., Ernlund, A., Zudock, K., Reno, A., Blount, K., & Karig, D. K. (2021) · Microbiome · doi:10.1186/s40168-020-00963-1 · Cited by 74 · see citing works
Using Spheroids as Building Blocks Towards 3D Bioprinting of Tumor Microenvironment
Zhuang, P., Chiang, Y., Fernanda, M. S., & He, M. L. (2021) · International Journal of Bioprinting · doi:10.18063/ijb.v7i4.444 · Cited by 73 · see citing works
Eberlin, S., da Silva, M. S., Facchini, G., da Silva, G. H., Pinheiro, A. L. T. A., Eberlin, S., & Pinheiro, A. D. S. (2020) · Alternatives to Laboratory Animals · doi:10.1177/0261192920914193 · Cited by 69 · see citing works
From Grafts to Human Bioengineered Vascularized Skin Substitutes
Oualla-Bachiri, W., Fernández-González, A., Quiñones-Vico, M. I., & Arias-Santiago, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218197 · Cited by 69 · see citing works
Ex Vivo Evaluation of Ethosomes and Transethosomes Applied on Human Skin: A Comparative Study
Esposito, E., Calderan, L., Galvan, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315112 · Cited by 69 · see citing works
Self-citationAlternative in vitro models used in the main safety tests of cosmetic products and new challenges
Filaire, E., Nachat, R., Camille, L., Harmand, M., Simon, M., & Poinsot, C. (2022) · International Journal of Cosmetic Science · doi:10.1111/ics.12803 · Cited by 67 · see citing works
Yang, Y., Xu, R., Wang, C., Guo, Y., Sun, W., & Ouyang, L. (2022) · International Journal of Bioprinting · doi:10.18063/ijb.v8i4.611 · Cited by 67 · see citing works
Skin microbiota and human 3D skin models
Rademacher, F., Simanski, M., Gläser, R., & Harder, J. (2018) · Experimental Dermatology · doi:10.1111/exd.13517 · Cited by 64 · see citing works
Jung, S.-Y., You, H. J., Kim, M.-J., Ko, G., Lee, S., & Kang, K.-S. (2022) · iScience · doi:10.1016/j.isci.2022.105150 · Cited by 63 · see citing works
Prasad, M., Kumar, R., Buragohain, L., Kumari, A., & Ghosh, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.696668 · Cited by 62 · see citing works
Luo, L., Patel, A., Sinko, B., Bell, M., Wibawa, J., Hadgraft, J., & Lane, M. E. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.03.043 · Cited by 59 · see citing works
An ex vivo Human Skin Model to Study Superficial Fungal Infections
Corzo-León, D., Munro, C. A., & MacCallum, D. M. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01172 · Cited by 57 · see citing works
Herbig, M. E., Houdek, P., Gorissen, S., et al. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.030 · Cited by 55 · see citing works
Xiang, H., Xu, S., Zhang, W., Li, Y., Zhou, Y., & Miao, X. (2023) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2023.113203 · Cited by 55 · see citing works
Sun, T. L., Norton, D. P., Haycock, J. W., et al. (2005) · Tissue Engineering · doi:10.1089/ten.2005.11.1824 · Cited by 54 · see citing works
Development of 3D skin-equivalent in a pump-less microfluidic chip
Song, H. J., Lim, H. Y., Chun, W., Choi, K. C., Lee, T.-Y., Sung, J. H., & Sung, G. Y. (2017) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2017.11.022 · Cited by 54 · see citing works
Ma, J., liu, J., Gao, D., Li, X., Zhang, Q., Lv, L., Wang, Y., Li, J., Zhu, Y., Wu, Z., et al. (2022) · Advanced Science · doi:10.1002/advs.202104192 · Cited by 53 · see citing works
Müller, G., Langer, J., Siebert, J. G. H., & Krämer, A. (2013) · Skin Pharmacology and Physiology · doi:10.1159/000350172 · Cited by 52 · see citing works
Generation of Skin Organoids: Potential Opportunities and Challenges
Sun, H., Zhang, Y., & Li, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.709824 · Cited by 52 · see citing works
Modeling an Optimal 3D Skin-on-Chip within Microfluidic Devices for Pharmacological Studies
Fernández-Carro, E., Angenent, M. L., Gracia‐Cazaña, T., Gilaberte, Y., Alcaine, C., & Ciriza, J. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14071417 · Cited by 47 · see citing works
Molecular action of isoflavone genistein in the human epithelial cell line HaCaT
Smolińska, E., Moskot, M., Jakóbkiewicz‐Banecka, J., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192297 · Cited by 47 · see citing works
Non-animal models in dermatological research
Dellambra, E. (2018) · ALTEX · doi:10.14573/altex.1808022 · Cited by 47 · see citing works
A novel human ex vivo skin model to study early local responses to burn injuries
Hofmann, E., Fink, J., Eberl, A., et al. (2021) · Scientific Reports · doi:10.1038/s41598-020-79683-3 · Cited by 47 · see citing works
Nowak, A., Cybulska, K., Makuch, E., et al. (2021) · Molecules · doi:10.3390/molecules26020329 · Cited by 45 · see citing works
Coenzyme Q10 Efficacy Test for Human Skin Equivalents Using a Pumpless Skin-On-A-Chip System
Kim, J., Kim, K., & Sung, G. Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228475 · Cited by 44 · see citing works
Challenges in developing a human model system for skin microbiome research
Larson, P. J., Chong, D., Fleming, E., & Oh, J. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.05.096 · Cited by 43 · see citing works
Simple and robust 3D bioprinting of full-thickness human skin tissue
Liu, J., Zhou, Z., Zhang, M., Song, F., Feng, C., & Liu, H. (2022) · Bioengineered · doi:10.1080/21655979.2022.2063651 · Cited by 41 · see citing works
Functional testing of topical skin formulations using an optimised ex vivo skin organ culture model
Sidgwick, G. P., McGeorge, D. D., & Bayat, A. (2016) · Archives of Dermatological Research · doi:10.1007/s00403-016-1645-8 · Cited by 41 · see citing works
3D bioprinting of an implantable xeno‐free vascularized human skin graft
Baltazar, T., Jiang, B., Moncayo, A. K., Merola, J., Albanna, M. Z., Saltzman, W. M., & Pober, J. S. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10324 · Cited by 41 · see citing works
Endogenous Antimicrobial Peptide Expression in Response to Bacterial Epidermal Colonization
Brandwein, M., Bentwich, Z., & Steinberg, D. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01637 · Cited by 39 · see citing works
Kim, K., Kim, J., Kim, H., & Sung, G. Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042160 · Cited by 38 · see citing works
A novel three‐dimensional model system for keloid study: Organotypic multicellular scar model
Lee, W. J., Choi, I., Lee, J. H., Kim, Y. O., & Yun, C. (2012) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2012.00869.x · Cited by 37 · see citing works
Lipid-Polymeric Films: Composition, Production and Applications in Wound Healing and Skin Repair
Souto, E. B., Yoshida, C. M. P., Leonardi, G. R., Cano, A. C., Sánchez‐López, E., Zielińska, A., Viseras, C., Severino, P. B., da Silva, C. F., & Barbosa, R. D. M. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13081199 · Cited by 36 · see citing works
Studying the Human Skin Microbiome Using 3D <i>In Vitro</i> Skin Models
Bojar, R. A. (2015) · Applied In Vitro Toxicology · doi:10.1089/aivt.2015.0002 · Cited by 36 · see citing works
Kirk, R. D., Akanji, T., Li, H., et al. (2022) · Medical Cannabis and Cannabinoids · doi:10.1159/000526769 · Cited by 33 · see citing works
Czajkowska-Kośnik, A., Szymańska, E., & Winnicka, K. (2022) · Molecules · doi:10.3390/molecules28010235 · Cited by 33 · see citing works
An in vitro model for bacterial growth on human stratum corneum
Krieken, D., Ederveen, T., Hijum, S., Jansen, P., Melchers, W., Scheepers, P., Schalkwijk, J., & Zeeuwen, P. (2016) · Acta Dermato Venereologica · doi:10.2340/00015555-2401 · Cited by 32 · see citing works
Skin microbiota analysis in human 3D skin models—“Free your mice”
Emmert, H., Rademacher, F., Gläser, R., & Harder, J. (2020) · Experimental Dermatology · doi:10.1111/exd.14164 · Cited by 32 · see citing works
Janvier, X., Alexandre, S., Boukerb, A. M., Souak, D., Maillot, O., Barreau, M., Gouriou, F., Grillon, C., Feuilloley, M. G. J., & Groboillot, A. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.591839 · Cited by 26 · see citing works
Vahav, I., Thon, M., van den Broek, L. J., Spiekstra, S. W., Ataç, B., Lindner, G., Schimek, K. M. S., Marx, U., & Gibbs, S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14081529 · Cited by 26 · see citing works
What can microfluidics do for human microbiome research?
Tan, H. Y., & Toh, Y. (2020) · Biomicrofluidics · doi:10.1063/5.0012185 · Cited by 25 · see citing works
Oceguera-Yañez, F., Ávila-Robinson, A., & Woltjen, K. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1030339 · Cited by 24 · see citing works
In Vitro and Ex Vivo Models for Screening Topical Anti-Inflammatory Drugs
Pérez-Salas, J. L., Moreno-Jiménez, M. R., Rocha-Guzmán, N. E., González-Laredo, R. F., Medina-Torres, L., & Gallegos-Infante, J. A. (2023) · Scientia Pharmaceutica · doi:10.3390/scipharm91020020 · Cited by 22 · see citing works
Shed king cobra and cobra skins as model membranes for in-vitro nicotine permeation studies
Pongjanyakul, T., Prakongpan, S., PANOMSUK, S. P., et al. (2002) · Journal of Pharmacy and Pharmacology · doi:10.1211/002235702760345419 · Cited by 22 · see citing works
Gruber, J. V., Terpak, N., Massard, S., Schwartz, A., & Bojanowski, K. (2023) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s391667 · Cited by 20 · see citing works
Cappellozza, E., Zanzoni, S., Malatesta, M., & Calderan, L. (2021) · Microscopy and Microanalysis · doi:10.1017/s1431927621012010 · Cited by 19 · see citing works
Self-citation2D vs. 3D Cell Culture Models for In Vitro Topical (Dermatological) Medication Testing
Teimouri, A., Yeung, P. K. F., & Agu, R. U. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.79868 · Cited by 18 · see citing works
Preparation and Evaluation of Vitamin D3 Supplementation as Transdermal Film-Forming Solution
Kittaneh, M., Qurt, M., Malkieh, N., Naseef, H., & Muqedi, R. H. M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics15010039 · Cited by 18 · see citing works
Quantification of Cannabis in Infused Consumer Products and Their Residues on Skin
Quiñones, R., Moreno, S., Smythers, A. L., Sullins, C., Pijor, H., Brown, G. J., Trouten, A., Richards‐Waugh, L. L., & Siddig, A. (2022) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.2c00077 · Cited by 17 · see citing works
Characterization of human skin equivalents developed at body's core and surface temperatures
Mieremet, A., Dijk, R., Boiten, W., Gooris, G., Bouwstra, J. A., & El Ghalbzouri, A. (2019) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2858 · Cited by 17 · see citing works
Köllmer, M., Mossahebi, P., Sacharow, E., Gorissen, S., Gräfe, N., Evers, D.-H., & Herbig, M. E. (2019) · AAPS PharmSciTech · doi:10.1208/s12249-019-1305-3 · Cited by 15 · see citing works
Idrees, A., Schmitz, I., Zoso, A., Gruhn, D., Pacharra, S., Shah, S., Ciardelli, G., Viebahn, R., Chiono, V., & Salber, J. (2021) · 4open · doi:10.1051/fopen/2021001 · Cited by 14 · see citing works
Changes in the skin microbiome during male maturation from 0 to 25 years of age
Hu, X., Tang, M., Dong, K., Zhou, J., Wang, D., & Song, L. (2023) · Skin Research and Technology · doi:10.1111/srt.13432 · Cited by 14 · see citing works
Ex vivo culture of lesional psoriasis skin for pharmacological testing
Tiirikainen, M. L., Woetmann, A., Norsgaard, H., et al. (2019) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2019.12.010 · Cited by 13 · see citing works
Rahma, A., Lane, M. E., & Sinkó, B. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.122692 · Cited by 12 · see citing works
Spontaneous immortalization of human dermal microvascular endothelial cells
Jiang, M. (2010) · World Journal of Stem Cells · doi:10.4252/wjsc.v2.i5.114 · Cited by 10 · see citing works
Cappellozza, E., Boschi, F., Sguizzato, M., et al. (2022) · European Journal of Histochemistry · doi:10.4081/ejh.2022.3321 · Cited by 10 · see citing works
Self-citationLandemaine, L., Cenizo, V., Lemaire, G., & Portes, P. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.03.973 · Cited by 9 · see citing works
Neil, J. E., Lenn, J. D., Brown, M. B., & Williams, A. C. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121610 · Cited by 9 · see citing works
Aiello, G., Rescigno, F., Méloni, M., Zoanni, B., Aldini, G., Carini, M., & D’Amato, A. (2023) · Antioxidants · doi:10.3390/antiox12020300 · Cited by 9 · see citing works
Being friendly to the skin microbiome: Experimental assessment
van Belkum, A., Lisotto, P., Pirovano, W., et al. (2023) · Frontiers in Microbiomes · doi:10.3389/frmbi.2022.1077151 · Cited by 9 · see citing works
An Innovative Fluid Dynamic System to Model Inflammation in Human Skin Explants
Galvan, A., Cappellozza, E., Pellequer, Y., Conti, A., Pozza, E. D., Vigato, E., Malatesta, M., & Calderan, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076284 · Cited by 8 · see citing works
Self-citationApproaches to the development of 3d bioprinted skin models: the case of natura cosmetics
Millás, A. L. G., Lago, J. C., Vasquez-Pinto, L. M. C., Massaguer, P. X. R., & Maria–Engler, S. S. (2019) · International Journal of Advances in Medical Biotechnology - IJAMB · doi:10.25061/2595-3931/ijamb/2019.v2i1.24 · Cited by 8 · see citing works
Ameri, M., Lewis, H., & Lehman, P. A. (2018) · Journal of Pharmaceutics · doi:10.1155/2018/7459124 · Cited by 7 · see citing works
Rohrbeck, A., Bruhn, V. A., Hussein, N., Hagemann, S., & Just, I. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02718-9 · Cited by 6 · see citing works
Probing the effects of sweet cherry (Prunus avium L.) extract on 2D and 3D human skin models
Letsiou, S., Ganopoulos, I. V., Kapazoglou, A., Xanthopoulou, A., Sarrou, E., Τάνου, Γ., & Molassiotis, A. N. (2022) · Molecular Biology Reports · doi:10.1007/s11033-021-07076-4 · Cited by 5 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- Haigh, J.M., Beyssac, E., and Aiache, J.-M. (1998, January 25–28). Can shed snake skin be considered to be a ‘model’ membrane for human stratum corneum?. Proceedings of the 2nd World Meeting APGI/APV, Paris, France.
Cited by
Sorted by citations
Cunha, L. B., Lepore, E. D., Medeiros, C. C. B., Sorrechia, R., Pietro, R. C. L. R., & Corrêa, M. A. (2024) · Life · doi:10.3390/life14081022 · Cited by 13 · see citing works
Diversity of human skin three-dimensional organotypic cultures
Jia, Y. Y., & Atwood, S. X. (2024) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2024.102275 · Cited by 12 · see citing works
Engineered Tissue Models to Decode Host–Microbiota Interactions
Adelfio, M., Callen, G. E., He, X., Paster, B. J., Hastürk, H., & Ghezzi, C. E. (2025) · Advanced Science · doi:10.1002/advs.202417687 · Cited by 6 · see citing works
Oliveira, C. S., de Melo, A. N. F., Ribeiro, T. B., Pintado, M., & Tavaria, F. K. (2025) · Fitoterapia · doi:10.1016/j.fitote.2025.106798 · Cited by 4 · see citing works
Galvan, A., Lacavalla, M. A., Boschi, F., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115397 · Cited by 4 · see citing works
Self-citationNeguț, I., Mazzanti, C., Laurano, R., Ciardelli, G., Bronco, S., & Oliveira, C. S. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1676663 · Cited by 4 · see citing works
Applying microbial ecology frameworks to microbial therapies for wildlife
Bornbusch, S. L., & Muletz‐Wolz, C. R. (2026) · mSystems · doi:10.1128/msystems.00598-25 · Cited by 1 · see citing works
Wang, K., & Zhang, J. (2026) · Journal of Science Advanced Materials and Devices · doi:10.1016/j.jsamd.2026.101177 · Cited by 1 · see citing works
Basch, L., Gopu, A., Welp, H., Mukarram, M., Imokhai, P. O., Huynh, K., Amin, S., & Jacobs, R. (2026) · Cureus · doi:10.7759/cureus.113304 · Cited by 1 · see citing works
Patatian, A., Ngari, C., Durand, C., Romain, D., Guéré, C., Vié, K., Poulet, V., Percoco, G., & Seyer, D. (2026) · BMC Microbiology · doi:10.1186/s12866-026-05316-w · Cited by 1 · see citing works
Toral-Orduno, J., Reddy, R. D., & Yusuf, N. (2026) · International Journal of Translational Medicine · doi:10.3390/ijtm6030039
- Authors
- Galvan, A., Pellicciari, C., & Calderan, L.
- Affiliations
- University of Verona (IT)
- University of Pavia (IT)
- Corresponding author
- Pellicciari, Carlo
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2024-01-18
- Volume
- 25
- Issue
- 2
- Pages
- 1165
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC10816982
- OpenAlex
- W4390985411
- Semantic Scholar
- 7c313a5fe37b550025f4b96e023fb63c0656a774
- Cited by
- 11
- References
- 140
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 2
- FWCI
- 3.70
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
- Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
- Keywords
- in vitro skin model, skin microbiome, skin barrier function, human skin, skin barrier, cosmetic agents, drug administration routes
- MeSH terms
- Health Status, Humans, Skin, Touch, Internationality, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-22.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-22.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review